Product Images Memantine Hydrochloride

The text describes a figure showing the time course of change from baseline in ADCS-ADL score for patients completing 28 weeks of treatment. It also includes information on clinical improvement and mean (+SEM) change from baseline.*

The text describes a figure (Figure 2) that shows the cumulative percentage of patients who completed 28 weeks of double-blind treatment and the specified changes from baseline in ADCS-ADL scores. The figure is represented on a graph with the x-axis indicating the change from baseline and the y-axis indicating the cumulative percentage of patients. There are some numbers and symbols in the figure that are difficult to decipher due to errors.*

This text describes a clinical graph showing the time course of change from baseline in SIB score for patients completing 28 weeks of treatment. The graph indicates a clinical improvement in SIB score for the patients.*

The text appears to be a figure caption or legend related to a medical study. It shows a graph titled "Cumulative percentage of patients completing 28 weeks of double-blind treatment with specified changes from baseline in SIB scores." The graph seems to document the effectiveness of a medication named Memantine HCI.*

The text is a description of a figure showing the percentage of patients completing 24 weeks of double-blind treatment with specified changes from baseline in ADCS-ADL scores. The figure compares the results of two treatments: Placebo/Donepezil and Memantine HCl/Donepezil. No further information is available.*

This is a visual representation of the change from baseline in SIB score for patients completing 24 weeks of treatment. The chart shows the mean (+ SEM) change from baseline for two different treatment groups: Placebo/Donepezil and Memantine HCI/Donepezil. The x-axis indicates the weeks of treatment and the y-axis indicates the change from baseline in the SIB score. The chart also indicates whether clinical improvement or decline occurred over time.*

This is a description of a medication called Memantine hydrochloride. The text includes instructions on how to store the medication, a warning to keep it out of reach of children, information about the manufacturer, the dosage form (tablet), the quantity (60 tablets), and limitations on its dispensing (Rx only). No additional context or information regarding the medication's usage or function is included.*